Please use this identifier to cite or link to this item:
Title: NATCO v. BAYER: Indian patent authority grants its first ever compulsory license on pharmaceutical products
Authors: Nedumpara, James J.
Misra, Prateek
Keywords: Indian Patent Authority
Pharmaceutical Products
Issue Date: 31-Dec-2012
Publisher: Wolters Kluwer
Citation: Nedumpara, James J. and Misra, Prateek. (2012). NATCO v. BAYER: Indian patent authority grants its first ever compulsory license on pharmaceutical products. Global Trade and Customs Journal, Vol.7 No.7/8 :326–330
Abstract: In an unprecedented move, the Controller of Patents in India has invoked the compulsory licensing provision of the Indian Patents Act to allow a domestic generic pharmaceutical company, viz., Natco Pharma to manufacture and sell the generic version of Bayer's patent-protected anti-cancer medicine, Nexavar (Sorafenib Tosylate) at a fraction of Bayer's selling price in India. The Controller of Patents reached the decision on the grounds that: (i) the reasonable requirements of the public with respect to patented invention are not met; (ii) that the patented invention was not available to the public at a reasonably affordable price; and (iii) that the patented invention has not been 'worked' in the territory of India. This decision has stirred a debate as to whether the grant of compulsory license could lead to weakening of intellectual property protection in India whereas several consumer and civil society organizations argue that this decision may usher in a new reality which requires the drug prices to be linked to the affordability of the consumers. The underlying message of this decision seems to be that no pharmaceutical company can afford to ignore a market if there are consumers suffering or dying in these countries for want of treatment by a product for which they hold the patent rights.
Description: Pdf not available, only citation
ISSN: 1569-755X
Appears in Collections:JGU Research Publications

Files in This Item:
File Description SizeFormat 
Nacto v Bayer.htmlpdf not available, only citation22.59 kBHTMLView/Open    Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.